SUBSCRIBE: Print / eNewsletter
Addressing Physical, Cognitive Effects of ADT in Prostate Cancer Patients
In this interview ahead of ASCO 2017 we discuss the physical and cognitive effects of androgen deprivation therapy in older men treated for prostate cancer.
Older Age Itself Rarely a Restriction to Treatment of Lung Cancer
Ahead of the 2017 ASCO Annual Meeting, we discuss how to approach treatment for older patients with lung cancer.
With Decades of Perspective, Craig Henderson Observes That Treatment of Breast Cancer Has Come a Long Way
In this interview we discuss important developments in the diagnosis and management of breast cancer and more.
Influence of Aerobic Exercise on QOL During Prostate Cancer Treatment
In this interview we discuss a study that looked at the effect of an 8-week exercise intervention on treatment side effects for patients with prostate cancer.
Pain Management in Cancer Patients at Risk of Opioid Abuse
In this interview we discuss pain management for cancer patients who are at high risk of opioid abuse.
Treating the Patient, Not the Disease: Fred Schiffman on Humanism in Medicine
In this interview we discuss humanistic medicine and some of the skills that physicians need in order to have open communication with their cancer patients, which can improve the quality of cancer care.
Atezolizumab in Triple-Negative Breast Cancer Improved Survival Among Responders
In this interview we discuss long-term data on the anti–PD-L1 immunotherapy atezolizumab in metastatic triple-negative breast cancer.
CTCs and Circulating Tumor DNA for the Monitoring of Breast Cancer Patients
In this interview we discuss the use of CTCs and circulating tumor DNA for prognosis and disease monitoring in patients with breast cancer.
Enhanced Recovery After Surgery for Ovarian Cancer Patients
In this interview we discuss the idea behind an enhanced recovery program for patients undergoing cytoreductive surgery for ovarian cancer, as well as some of the potential cost savings.
Cancer Treatment for LGBTQ Patients
In this interview we discuss the approach to treating cancer in lesbian, gay, bisexual, transgender, and queer (LGBTQ) patients.